CGM Study Shows Sex Is Safe for Type 1 Diabetes
A small study using continuous glucose monitors suggests sexual activity does not pose a safety risk for people with type 1 diabetes.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
Pharma Marketers Urged to Use Humor and Authenticity at Fierce Pharma Week
Industry marketing leaders gathered in Philadelphia to emphasize creative, genuine approaches in a shifting consumer landscape.
Aptitude's Next-Gen Metrix COVID Test Wins First 510(k) Clearance
The updated Metrix molecular diagnostic moves from emergency use to traditional FDA clearance, with higher sensitivity and faster results.
FDA pilot program aims to accelerate phase 1 trial approvals
The agency opens an expedited IND pathway to help U.S. early-stage trials keep pace with China.
Damon Wayans uses comedy for Genentech DME awareness campaign
The comedian and type 2 diabetic is partnering with Genentech to spotlight diabetic macular edema through humor and personal experience.
EU Panel Backs Novo Hemophilia A Drug and AZ Offerings
Europe's drug advisory body issued positive opinions for a batch of medicines, including a next-generation hemophilia A therapy from Novo Nordisk and new products from AstraZeneca.
SK Biopharma Adds Preclinical Parkinson’s Candidate in $315M Deal
SK Biopharmaceuticals is expanding its Parkinson’s pipeline with a second preclinical asset from a South Korean partner in a deal worth up to $314.8 million.
Bavarian Nordic names Sanofi, AstraZeneca veteran as next CEO
The Danish vaccine maker is turning to a pharma industry veteran to succeed longtime CEO Paul Chaplin.
Agentic AI Points to New Automation Era for Clinical Trials
A sponsored Fierce Pharma analysis says agentic AI could tie together fragmented clinical trial workflows and accelerate execution.
FDA Warns Bausch & Lomb Over Tampa Eye-Med Plant Contamination
The FDA has issued a warning letter to Bausch & Lomb over contamination concerns at its Tampa, Florida, facility that makes prescription and over-the-counter eye medications.
Roche's Lunsumio Meets Primary Endpoint in Earlier-Line Follicular Lymphoma
A confirmatory phase 3 trial showed Roche's T-cell engager Lunsumio achieved its primary endpoint in earlier-line follicular lymphoma.
Biopharma Prediction Markets Raise Insider and Trial-Integrity Concerns
A growing niche of markets lets traders bet on trial outcomes, creating new risks around insider information and the integrity of clinical trials.
New Weekly Tracker to Follow Oral GLP-1 Prescription Race
Fierce Pharma launches a weekly data-driven tracker to monitor how Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo compete for the oral weight-loss market.
Swedish Trial Finds Mepivacaine Eases IUD Insertion Pain
A randomized trial from Sweden shows that placing the anesthetic mepivacaine inside the uterus reduces pain during IUD placement.
Ayble Health Raises $16M for Virtual Digestive Care
The Series A funding will help Ayble Health scale its virtual clinic for digestive health conditions.
Ascension sells Arizona Medicaid plan stake to Aetna
The deal lets Ascension offload insurance risk while giving Aetna a share of a profitable dual-eligible plan.
Goa Therapeutics exits stealth to develop a 'Narcan for alcohol'
The startup aims to create a rapid anti-intoxication drug that works like naloxone does for opioids.
Food as Medicine Field Sees Research and Policy Surge
A single report highlights a landmark year for food-is-medicine, marked by a rapid rise in studies and policy advances.